NPY1R and atherosclerosis: Therefore, NPYR present in macrophages appears to be an important pathway by which NPY stimulates macrophage chemotaxis, implying that the antagonism of excessive NPYR activation could be a potential therapeutic target for the complications associated with atherosclerosis.